Cervicovaginal fetal fibronectin for the prediction of spontaneous preterm birth in multiple pregnancies: a systematic review and meta-analysis

References

• Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75–84.
   PubMed Web of Science ®Google Scholar
• Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S, Mathews TJ. Births: final data for 2006. National vital statistics reports. Hyatsville, MD: National Center for Health Statistics; 2009. Vol. 57, No 7.
   Google Scholar
• Ananth CV, Joseph KS, Oyelese Y, Demissie K, Vintzileos AM. Trends in preterm birth and perinatal mortality among singletons: United States, 1989 through 2000. Obstet Gynecol 2005;105:1084–1091.
   PubMed Web of Science ®Google Scholar
• Reynolds MA, Schieve LA, Martin JA, Jeng G, Macaluso M. Trends in multiple births conceived using assisted reproductive technology, United States, 1997–2000. Pediatrics 2003;111:1159–1162.
   PubMed Web of Science ®Google Scholar
• Chuileannáin FN, Brennecke S. Prediction of preterm labour in multiple pregnancies. Baillieres Clin Obstet Gynaecol 1998;12:53–66.
   PubMedGoogle Scholar
• Feinberg RF, Kliman HJ, Lockwood CJ. Is oncofetal fibronectin a trophoblast glue for human implantation? Am J Pathol 1991;138:537–543.
   PubMed Web of Science ®Google Scholar
• Ascarelli MH, Morrison JC. Use of fetal fibronectin in clinical practice. Obstet Gynecol Surv 1997;52:S1–S12.
   PubMedGoogle Scholar
• Lockwood CJ, Senyei AE, Dische MR, Casal D, Shah KD, Thung SN, Jones L, Deligdisch L, Garite TJ. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991;325:669–674.
   PubMed Web of Science ®Google Scholar
• Chien PF, Khan KS, Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview. Br J Obstet Gynaecol 1997;104:436–444.
   PubMedGoogle Scholar
• Faron G, Boulvain M, Irion O, Bernard PM, Fraser WD. Prediction of preterm delivery by fetal fibronectin: a meta-analysis. Obstet Gynecol 1998;92:153–158.
   PubMed Web of Science ®Google Scholar
• Revah A, Hannah ME, Sue-A-Quan AK. Fetal fibronectin as a predictor of preterm birth: an overview. Am J Perinatol 1998;15:613–621.
   PubMed Web of Science ®Google Scholar
• Leitich H, Egarter C, Kaider A, Hohlagschwandtner M, Berghammer P, Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol 1999;180:1169–1176.
   PubMed Web of Science ®Google Scholar
• Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. Br Med J 2002;325:301.
   PubMed Web of Science ®Google Scholar
• Leitich H, Kaider A. Fetal fibronectin – how useful is it in the prediction of preterm birth? BJOG 2003;110:66–70.
   PubMed Web of Science ®Google Scholar
• Leeflang MM, Deeks JJ, Gatsonis C, Bossuyt PM. Cochrane Diagnostic Test Accuracy Working Group. Systematic reviews of diagnostic test accuracy. Ann Intern Med 2008;149: 889–897.
   PubMed Web of Science ®Google Scholar
• Lijmer JG, Mol BW, Heisterkamp S, Bonsel GJ, Prins MH, van der Meulen JHP, Bossuyt PM. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999;282: 1061–1066.
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.
   PubMedGoogle Scholar
• Whiting P, Harbord R, Kleijnen J. No role for quality scores in systematic reviews of diagnostic accuracy studies. BMC Med Res Methodol 2005;5:19.
   PubMedGoogle Scholar
• Sankey S, Weisfiels L, Fine M, Kapoor W. An assessment of the use of the continuity correction for sparse data in meta-analysis. Commun Stat Simul Comput 1996;25:1031–1056.
   Web of Science ®Google Scholar
• Reitsma JB, Glas AS, Rutjes AW, Scholten RJ, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol 2005;58:982–990.
   PubMed Web of Science ®Google Scholar
• Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 2002;21:1237–1256.
   PubMed Web of Science ®Google Scholar
• Zwinderman AH, Bossuyt PM. We should not pool diagnostic likelihood ratios in systematic reviews. Stat Med 2008;27: 687–697.
   PubMed Web of Science ®Google Scholar
• Jaeschke R, Guyatt GH, Sackett DL. Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA 1994;271:703–707.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Br Med J 2003;327:557–560.
   PubMed Web of Science ®Google Scholar
• Lijmer JG, Bossuyt PM, Heisterkamp SH. Exploring sources of heterogeneity in systematic reviews of diagnostic tests. Stat Med 2002;21:1525–1537.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analyses detected by a simple graphical test. Br Med J 1997;315:629–634.
   PubMed Web of Science ®Google Scholar
• Tolino A, Ronsini S, Zullo F, Pellicano M, Regine V, Nappi C. Fetal fibronectin as a screening test for premature delivery in multiple pregnancies. Int J Gynaecol Obstet 1996;52:3–7.
   PubMed Web of Science ®Google Scholar
• Morrison JC, Naef RW III, Botti JJ, Katz M, Belluomini JM, McLaughlin BN. Prediction of spontaneous preterm birth by fetal fibronectin and uterine activity. Obstet Gynecol 1996;87:649–655.
   PubMed Web of Science ®Google Scholar
• Goldenberg RL, Iams JD, Miodovnik M, Van Dorsten JP, Thurnau G, Bottoms S, Mercer BM, Meis PJ, Moawad AH, Das A, et al. The preterm prediction study: risk factors in twin gestations. National Institute of Child Health and Human Development Maternal–Fetal Medicine Units Network. Am J Obstet Gynecol 1996;175:1047–1053.
   PubMed Web of Science ®Google Scholar
• Wennerholm UB, Holm B, Mattsby-Baltzer I, Nielsen T, Platz-Christensen J, Sundell G, Hosseini N, Hagberg H. Fetal fibronectin, endotoxin, bacterial vaginosis and cervical length as predictors of preterm birth and neonatal morbidity in twin pregnancies. Br J Obstet Gynaecol 1997;104:1398–1404.
   PubMedGoogle Scholar
• Oliveira T, de Souza E, Mariani-Neto C, Camano L. Fetal fibronectin as a predictor of preterm delivery in twin gestations. Int J Gynaecol Obstet 1998;62:135–139.
   PubMed Web of Science ®Google Scholar
• Ramirez M, Turrentine M. Comparison of fetal fibronectin and home uterine monitoring as predictors of preterm delivery in twin gestations. Am J Obstet Gynecol 1999;180S:104S.
   Google Scholar
• McMahon KS, Neerhof MG, Haney EI, Thomas HA, Silver RK, Peaceman AM. Prematurity in multiple gestations: identification of patients who are at low risk. Am J Obstet Gynecol 2002;186:1137–1141.
   PubMed Web of Science ®Google Scholar
• Gibson JL, Macara LM, Owen P, Young D, Macauley J, Mackenzie F. Prediction of preterm delivery in twin pregnancy: a prospective, observational study of cervical length and fetal fibronectin testing. Ultrasound Obstet Gynecol 2004;23:561–566.
   PubMed Web of Science ®Google Scholar
• Ruiz RJ, Fullerton J, Brown CE. The utility of fFN for the prediction of preterm birth in twin gestations. J Obstet Gynecol Neonatal Nurs 2004;33:446–454.
   PubMed Web of Science ®Google Scholar
• Roman AS, Koklanaris N, Paidas MJ, Mulholland J, Levitz M, Rebarber A. “Blind” vaginal fetal fibronectin as a predictor of spontaneous preterm delivery. Obstet Gynecol 2005;105:285–289.
   PubMed Web of Science ®Google Scholar
• Fox NS, Saltzman DH, Klauser CK, Peress D, Gutierrez CV, Rebarber A. Prediction of spontaneous preterm birth in asymptomatic twin pregnancies with the use of combined fetal fibronectin and cervical length. Am J Obstet Gynecol 2009;201:313.e1–e5.
   Web of Science ®Google Scholar
• Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Iams JD, Coultrip L, Eriksen N, Holbrook RH, Elliott J, et al. Fetal fibronectin as a predictor of preterm birth in patients with symptoms: a multicenter trial. Am J Obstet Gynecol 1997;177:13–18.
   PubMed Web of Science ®Google Scholar
• Terrone DA, Rinehart BK, Kraeden U, Morrison JC. Fetal fibronectin in symptomatic twin gestations. Prim Care Update Ob Gyns 1998;5:179.
   PubMedGoogle Scholar
• Gonzalez N, Bige V, Kandoussi S, Graesslin O, Quereux C, Gabriel R. Ultrasonographic measurement of cervical length in twin pregnancies with preterm labor: comparison with singleton pregnancies [In French]. Gynecol Obstet Fertil 2004;32:122–127.
   PubMedGoogle Scholar
• Singer E, Pilpel S, Bsat F, Plevyak M, Healy A, Markenson G. Accuracy of fetal fibronectin to predict preterm birth in twin gestations with symptoms of labor. Obstet Gynecol 2007;109:1083–1087.
   PubMed Web of Science ®Google Scholar
• Whiting P, Rutjes AW, Reitsma JB, Glas AS, Bossuyt PM, Kleijnen J. Sources of variation and bias in studies of diagnostic accuracy: a systematic review. Ann Intern Med 2004;140:189–202.
   PubMed Web of Science ®Google Scholar
• Rutjes AW, Reitsma JB, Di Nisio M, Smidt N, van Rijn JC, Bossuyt PM. Evidence of bias and variation in diagnostic accuracy studies. CMAJ 2006;174:469–476.
   PubMed Web of Science ®Google Scholar
• Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2008;4:CD006843.
   PubMed Web of Science ®Google Scholar